Reactive Astrocytes Overexpress TSPO and Are Detected by TSPO Positron Emission Tomography Imaging

Astrocytes and microglia become reactive under most brain pathological conditions, making this neuroinflammation process a surrogate marker of neuronal dysfunction. Neuroinflammation is associated with increased levels of translocator protein 18 kDa (TSPO) and binding sites for TSPO ligands. Positron emission tomography (PET) imaging of TSPO is thus commonly used to monitor neuroinflammation in preclinical and clinical studies. It is widely considered that TSPO PET signal reveals reactive microglia, although a few studies suggested a potential contribution of reactive astrocytes. Because astrocytes and microglia play very different roles, it is crucial to determine whether reactive astrocytes can also overexpress TSPO and yield to a detectable TSPO PET signal in vivo. We used a model of selective astrocyte activation through lentiviral gene transfer of the cytokine ciliary neurotrophic factor (CNTF) into the rat striatum, in the absence of neurodegeneration. CNTF induced an extensive activation of astrocytes, which overexpressed GFAP and become hypertrophic, whereas microglia displayed minimal increase in reactive markers. Two TSPO radioligands, [18F]DPA-714 [N,N-diethyl-2-(2-(4-(2-[18F]fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide] and [11C]SSR180575 (7-chloro-N,N-dimethyl-5-[11C]methyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), showed a significant binding in the lenti-CNTF-injected striatum that was saturated and displaced by PK11195 [N-methyl-N-(1-methylpropyl)-1-(2-chlorophenyl)-isoquinoline-3-carboxamide]. The volume of radioligand binding matched the GFAP immunopositive volume. TSPO mRNA levels were significantly increased, and TSPO protein was overexpressed by CNTF-activated astrocytes. We show that reactive astrocytes overexpress TSPO, yielding to a significant and selective binding of TSPO radioligands. Therefore, caution must be used when interpreting TSPO PET imaging in animals or patients because reactive astrocytes can contribute to the signal in addition to reactive microglia.

[1]  Richard S. J. Frackowiak,et al.  Macrophage and Astrocyte Populations in Relation to [3H]PK 11195 Binding in Rat Cerebral Cortex following a Local Ischaemic Lesion , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  T. Guilarte,et al.  Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  Radiosynthesis of 7-chloro-N,N-dimethyl-5-[11C]methyl-4-oxo-3- phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, [11C] SSR180575, a novel radioligand for imaging the TSPO (peripheral benzodiazepine receptor) with PET , 2010 .

[4]  A. Wree,et al.  Quinolinic acid lesions of the caudate putamen in the rat lead to a local increase of ciliary neurotrophic factor , 2004, Journal of anatomy.

[5]  S. Wiegand,et al.  Injury‐induced Regulation of Ciliary Neurotrophic Factor mRNA in the Adult Rat Brain , 1993, The European journal of neuroscience.

[6]  A. Reynolds,et al.  Initial evaluation in healthy humans of [18F]DPA-714, a potential PET biomarker for neuroinflammation. , 2012, Nuclear medicine and biology.

[7]  Alexander Gerhard,et al.  In vivo imaging of neuroinflammation , 2002, European Neuropsychopharmacology.

[8]  Makoto Sawada,et al.  Imaging of Peripheral Benzodiazepine Receptor Expression as Biomarkers of Detrimental versus Beneficial Glial Responses in Mouse Models of Alzheimer's and Other CNS Pathologies , 2008, The Journal of Neuroscience.

[9]  Annelaure Damont,et al.  Evaluation of the PBR/TSPO Radioligand [18F]DPA-714 in a Rat Model of Focal Cerebral Ischemia , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  S. Akira,et al.  STAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury , 2008, The Journal of Neuroscience.

[11]  Gerhard Rammes,et al.  Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders , 2010, Nature Reviews Drug Discovery.

[12]  Hideyuki Okano,et al.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury , 2006, Nature Medicine.

[13]  B. Tavitian,et al.  In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa) , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  Marc Dhenain,et al.  Activation of Astrocytes by CNTF Induces Metabolic Plasticity and Increases Resistance to Metabolic Insults , 2007, The Journal of Neuroscience.

[15]  T. Guilarte,et al.  Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.

[16]  Michael Kassiou,et al.  Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. , 2009, Current medicinal chemistry.

[17]  F. Cicchetti,et al.  Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions , 2011, Glia.

[18]  Tetsuya Suhara,et al.  A comparison of the high‐affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)‐PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation , 2007, Journal of neurochemistry.

[19]  R. Swanson,et al.  Nuclear Factor Erythroid 2-Related Factor 2 Facilitates Neuronal Glutathione Synthesis by Upregulating Neuronal Excitatory Amino Acid Transporter 3 Expression , 2011, The Journal of Neuroscience.

[20]  V. Papadopoulos,et al.  Regulation of translocator protein 18kDa (TSPO) expression in health and disease states , 2010, Molecular and Cellular Endocrinology.

[21]  Denis Guilloteau,et al.  DPA-714, a New Translocator Protein–Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization , 2008, Journal of Nuclear Medicine.

[22]  P. Gubellini,et al.  Ciliary Neurotrophic Factor Protects Striatal Neurons against Excitotoxicity by Enhancing Glial Glutamate Uptake , 2010, PloS one.

[23]  Michael Kassiou,et al.  The Translocator Protein , 2011, The Journal of Nuclear Medicine.

[24]  B. Tavitian,et al.  Radiosynthesis of [18F]PBR111, a selective radioligand for imaging the translocator protein (18 kDa) with PET , 2008 .

[25]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[26]  Vincent Frouin,et al.  Automated Three-Dimensional Analysis of Histological and Autoradiographic Rat Brain Sections: Application to an Activation Study , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Sébastien Ourselin,et al.  Reconstructing a 3D structure from serial histological sections , 2001, Image Vis. Comput..

[28]  Hervé Boutin,et al.  Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  C. Wiley,et al.  Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease , 2009, Journal of Neuroimmune Pharmacology.

[30]  Jordi Llop,et al.  Imaging Brain Inflammation with [11C]PK11195 by PET and Induction of the Peripheral-Type Benzodiazepine Receptor after Transient Focal Ischemia in Rats , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[31]  T. Guilarte,et al.  Cellular and Subcellular Localization of Peripheral Benzodiazepine Receptors After Trimethyltin Neurotoxicity , 2000, Journal of neurochemistry.

[32]  RockOn Team,et al.  Re: Attenuation compensation in single-photon emission tomography: a comparative evaluation. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  B. Lopresti,et al.  The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imaging , 2006, Progress in Neurobiology.

[34]  Paul Cumming,et al.  Up‐regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain , 2006, The European journal of neuroscience.

[35]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[36]  Gilles Bonvento,et al.  Targeted Activation of Astrocytes: A Potential Neuroprotective Strategy , 2008, Molecular Neurobiology.

[37]  Philippe Hantraye,et al.  Ciliary Neurotrophic Factor Activates Astrocytes, Redistributes Their Glutamate Transporters GLAST and GLT-1 to Raft Microdomains, and Improves Glutamate Handling In Vivo , 2006, The Journal of Neuroscience.

[38]  M. Sofroniew,et al.  Reactive astrocytes as therapeutic targets for CNS disorders , 2010, Neurotherapeutics.

[39]  Hyun B Choi,et al.  Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum , 2005, Neurobiology of Disease.

[40]  Tetsuya Suhara,et al.  Phase-dependent roles of reactive microglia and astrocytes in nervous system injury as delineated by imaging of peripheral benzodiazepine receptor , 2007, Brain Research.

[41]  Annelaure Damont,et al.  Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation , 2009, Journal of Nuclear Medicine.

[42]  Marios Politis,et al.  Positron emission tomography imaging in neurological disorders , 2012, Journal of Neurology.

[43]  H. Engler,et al.  Evidence for astrocytosis in ALS demonstrated by [11C](l)-deprenyl-D2 PET , 2007, Journal of the Neurological Sciences.